Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.1700
+0.0050 (3.03%)
Sep 4, 2026, 4:18 PM GMT
Nuformix Market Cap
Nuformix has a market cap or net worth of 4.31 million as of September 4, 2026. Its market cap has increased by 115.77% in one year.
Market Cap
4.31M
Enterprise Value
3.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
ChartMarket Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 4.31M, a decrease of -75.08%. That is a compound annual growth rate of -14.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 4.31M | -19.96% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 8.00M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |
| Oxford BioDynamics | 5.15M |
| Theracryf | 4.08M |
| Physiomics | 2.33M |